CIDARA THERAPEUTICS, INC.
Profile
Company Names
CIDARA THERAPEUTICS, INC.
K2 THERAPEUTICS, INC.
Addresses
6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO, CA 92121
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA 92121
Phone Numbers
858-752-6170
781-314-1105
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2012
State Incorporated:
DELAWARE
Total Amount Raised:
$318,751,143.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2024-04-24
$240,000,000.00
$240,000,000.00
$0.00
Equity
5
2019-09-03
$9,008,173.00
$9,008,173.00
$0.00
Equity
4
2018-05-23
$1,562,499.00
$1,874,999.00
$312,500.00
3
2017-10-24
$20,160,000.00
$20,160,000.00
$0.00
Equity
2
2015-02-10
$42,019,999.00
$42,019,999.00
$0.00
Equity
1
2014-05-30
$6,000,472.00
$6,000,472.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVE
ELMS
DIRECTOR
KEVIN
FORREST
EXECUTIVE OFFICER
PATRICK
HERON
DIRECTOR
QUATRX PHARMACEUTICALS CO
| TRUBION PHARMACEUTICALS, INC
| COLLEGIUM PHARMACEUTICAL INC
| VENTIRX PHARMACEUTICALS INC
| TOBIRA THERAPEUTICS, INC.
| KALIDEX PHARMACEUTICALS, INC.
| PRECISION DERMATOLOGY, INC.
| INFORMED MEDICAL COMMUNICATIONS, INC.
| SILVERGATE PHARMACEUTICALS, INC.
| VENTIRX PHARMACEUTICALS INC.
| FRAZIER HEALTHCARE VII-A, L.P.
| FRAZIER HEALTHCARE VII, L.P.
| K2 THERAPEUTICS, INC.
| IMAGO BIOSCIENCES, INC.
| COLLEGIUM PHARMACEUTICAL, INC
| CIDARA THERAPEUTICS, INC.
| NEXCIDA THERAPEUTICS, INC.
| ITERUM THERAPEUTICS LTD
| ZAVANTE THERAPEUTICS, INC.
| SUTROVAX, INC.
| SCOUT BIO, INC.
| RECIDA THERAPEUTICS, INC.
| MIRUM PHARMACEUTICALS, INC.
| PASSAGE BIO, INC.
| ARCUTIS BIOTHERAPEUTICS, INC.
| MBX BIOSCIENCES, INC.
KEVIN
JUDICE
EXECUTIVE OFFICER, DIRECTOR
NINA
KJELLSON
DIRECTOR
LYCERA CORP
| PRIMERA BIOSYSTEMS INC
| PRIMERADX, INC.
| ALVINE PHARMACEUTICALS INC
| SEQUEL PHARMACEUTICALS INC
| CNS THERAPEUTICS INC
| TRIUS THERAPEUTICS INC
| CEBIX INCOPRATED
| CEBIX INC
| EIGER BIOPHARMACEUTICALS INC
| OCERA THERAPEUTICS INC
| WELLTOK, INC.
| OCERA THERAPEUTICS, INC.
| K2 THERAPEUTICS, INC.
| CIDARA THERAPEUTICS, INC.
| EIGER BIOPHARMACEUTICALS, INC.
| ANNUM HEALTH, INC.
| VINETI, INC.
| TYRA BIOSCIENCES, INC.
SCOTT
ROCKLAGE
DIRECTOR
RENNOVIA INC
| PULMATRIX INC
| 5AM CO-INVESTORS III, L.P.
| ACHAOGEN INC
| RELYPSA INC
| WAVERX INC
| SEMPRUS BIOSCIENCES CORP
| VARIATION BIOTECHNOLOGIES (US), INC.
| KINESTRAL TECHNOLOGIES, INC.
| NOVIRA THERAPEUTICS, INC.
| 5AM CO-INVESTORS IV, L.P.
| K2 THERAPEUTICS, INC.
| CIDARA THERAPEUTICS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| EXPANSION THERAPEUTICS, INC.
| ALBAMUNITY, INC.
THEODORE
R.
SCHROEDER
DIRECTOR
JEFFREY
STEIN
EXECUTIVE OFFICER, DIRECTOR
DIRK
THYE
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2024-04-24
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-09-03
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2018-05-23
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2017-10-24
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2015-02-10
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

